Prognostic Value of SLC16A3(MCT4) in Lung Adenocarcinoma and Its Clinical Significance

References

• Graham TA, Sottoriva A. Measuring cancer evolution from the genome. J Pathol. 2017;241(2):183–191. doi:10.1002/path.4821
   PubMed Web of Science ®Google Scholar
• Vazquez A, Kamphorst JJ, Markert EK, Schug ZT, Tardito S, Gottlieb E. Cancer metabolism at a glance. J Cell Sci. 2016;129(18):3367–3373. doi:10.1242/jcs.181016
   PubMed Web of Science ®Google Scholar
• Koundouros N, Poulogiannis G. Reprogramming of fatty acid metabolism in cancer. Br J Cancer. 2020;122(1):4–22. doi:10.1038/s41416-019-0650-z
   PubMed Web of Science ®Google Scholar
• Liberti MV, Locasale JW. The Warburg effect: how does it benefit cancer cells? Trends Biochem Sci. 2016;41(3):211–218. doi:10.1016/j.tibs.2015.12.001
   PubMed Web of Science ®Google Scholar
• Pascale RM, Calvisi DF, Simile MM, Feo CF, Feo F. The Warburg Effect 97 Years after Its Discovery. Cancers. 2020;12(10):2819. doi:10.3390/cancers12102819
   PubMed Web of Science ®Google Scholar
• Jing X, Yang F, Shao C, et al. Role of hypoxia in cancer therapy by regulating the tumor microenvironment. Mol Cancer. 2019;18(1):157. doi:10.1186/s12943-019-1089-9
   PubMed Web of Science ®Google Scholar
• Xie J, Ruan S, Zhu Z, et al. Database mining analysis revealed the role of the putative H+/sugar transporter solute carrier family 45 in skin cutaneous melanoma. Channels. 2021;15(1):496–506. doi:10.1080/19336950.2021.1956226
   PubMed Web of Science ®Google Scholar
• Xie J, Zhu Z, Cao Y, Ruan S, Wang M, Shi J. Solute carrier transporter superfamily member SLC16A1 is a potential prognostic biomarker and associated with immune infiltration in skin cutaneous melanoma. Channels. 2021;15(1):483–495. doi:10.1080/19336950.2021.1953322
   PubMed Web of Science ®Google Scholar
• Watson MJ, Vignali PDA, Mullett SJ, et al. Metabolic support of tumour-infiltrating regulatory T cells by lactic acid. Nature. 2021;591(7851):645–651. doi:10.1038/s41586-020-03045-2
   PubMed Web of Science ®Google Scholar
• Park SJ, Smith CP, Wilbur RR, et al. An overview of MCT1 and MCT4 in GBM: small molecule transporters with large implications. Am J Cancer Res. 2018;8(10):1967–1976.
   PubMed Web of Science ®Google Scholar
• Choi SH, Kim MY, Yoon YS, et al. Hypoxia-induced RelA/p65 derepresses SLC16A3 (MCT4) by downregulating ZBTB7A. Biochim Biophys Acta Gene Regul Mech. 2019;1862(8):771–785. doi:10.1016/j.bbagrm.2019.06.004
   PubMed Web of Science ®Google Scholar
• Nasim F, Sabath BF, Eapen GA. Lung Cancer. Med Clin North Am. 2019;103(3):463–473. doi:10.1016/j.mcna.2018.12.006
   PubMed Web of Science ®Google Scholar
• Collins LG, Haines C, Perkel R, Enck RE. Lung cancer: diagnosis and management. Am Fam Physician. 2007;75(1):56–63.
   PubMed Web of Science ®Google Scholar
• Mao Y, Yang D, He J, Krasna MJ. Epidemiology of Lung Cancer. Surg Oncol Clin N Am. 2016;25(3):439–445. doi:10.1016/j.soc.2016.02.001
   PubMed Web of Science ®Google Scholar
• de Sousa VML, Carvalho L. Heterogeneity in Lung Cancer. Pathobiology. 2018;85(1–2):96–107. doi:10.1159/000487440
   PubMed Web of Science ®Google Scholar
• Chandrashekar DS, Bashel B, Balasubramanya SAH, et al. UALCAN: a Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses. Neoplasia. 2017;19(8):649–658. doi:10.1016/j.neo.2017.05.002
   PubMed Web of Science ®Google Scholar
• Szklarczyk D, Morris JH, Cook H, et al. The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible. Nucleic Acids Res. 2017;45(D1):D362–D368. doi:10.1093/nar/gkw937
   PubMed Web of Science ®Google Scholar
• Chae YK, Oh MS. Detection of Minimal Residual Disease Using ctDNA in Lung Cancer: current Evidence and Future Directions. J Thorac Oncol. 2019;14(1):16–24. doi:10.1016/j.jtho.2018.09.022
   PubMed Web of Science ®Google Scholar
• Villalobos P, Wistuba II. Lung Cancer Biomarkers. Hematol Oncol Clin North Am. 2017;31(1):13–29. doi:10.1016/j.hoc.2016.08.006
   PubMed Web of Science ®Google Scholar
• Park JH, Pyun WY, Park HW. Cancer Metabolism: phenotype, Signaling and Therapeutic Targets. Cells. 2020;9(10):2308. doi:10.3390/cells9102308
   PubMed Web of Science ®Google Scholar
• Momcilovic M, Shackelford DB. Imaging Cancer Metabolism. Biomol Ther (Seoul). 2018;26(1):81–92. doi:10.4062/biomolther.2017.220
   PubMed Web of Science ®Google Scholar
• Farber S, Farber S. Some observations on the effect of folic acid antagonists on acute leukemia and other forms of incurable cancer. Blood. 1949;4(2):160–167. doi:10.1182/blood.V4.2.160.160
   PubMed Web of Science ®Google Scholar
• Li Z, Zhang H. Reprogramming of glucose, fatty acid and amino acid metabolism for cancer progression. Cell Mol Life Sci. 2016;73(2):377–392. doi:10.1007/s00018-015-2070-4
   PubMed Web of Science ®Google Scholar
• Semenza GL. Hypoxia-inducible factors: coupling glucose metabolism and redox regulation with induction of the breast cancer stem cell phenotype. EMBO J. 2017;36(3):252–259. doi:10.15252/embj.201695204
   PubMed Web of Science ®Google Scholar
• Duffy MJ, Synnott NC, Crown J. Mutant p53 as a target for cancer treatment. Eur J Cancer. 2017;83:258–265. doi:10.1016/j.ejca.2017.06.023
   PubMed Web of Science ®Google Scholar
• He X, Lee B, Jiang Y. Cell-ECM Interactions in Tumor Invasion. Adv Exp Med Biol. 2016;936:73–91.
   PubMed Web of Science ®Google Scholar
• Paluch EK, Aspalter IM, Sixt M. Focal Adhesion-Independent Cell Migration. Annu Rev Cell Dev Biol. 2016;32:469–490. doi:10.1146/annurev-cellbio-111315-125341
   PubMed Web of Science ®Google Scholar
• Eke I, Cordes N. Focal adhesion signaling and therapy resistance in cancer. Semin Cancer Biol. 2015;31:65–75. doi:10.1016/j.semcancer.2014.07.009
   PubMed Web of Science ®Google Scholar
• Desrichard A, Snyder A, Chan TA. Cancer Neoantigens and Applications for Immunotherapy. Clin Cancer Res. 2016;22(4):807–812. doi:10.1158/1078-0432.CCR-14-3175
   PubMed Web of Science ®Google Scholar
• Lei Q, Wang D, Sun K, Wang L, Zhang Y. Resistance Mechanisms of Anti-PD1/PDL1 Therapy in Solid Tumors. Front Cell Dev Biol. 2020;8:672. doi:10.3389/fcell.2020.00672
   PubMed Web of Science ®Google Scholar
• Li N, Kang Y, Wang L, et al. ALKBH5 regulates anti-PD-1 therapy response by modulating lactate and suppressive immune cell accumulation in tumor microenvironment. Proc Natl Acad Sci U S A. 2020;117(33):20159–20170. doi:10.1073/pnas.1918986117
   PubMed Web of Science ®Google Scholar
• Yu S, Wu Y, Li C, et al. Comprehensive analysis of the SLC16A gene family in pancreatic cancer via integrated bioinformatics. Sci Rep. 2020;10(1):7315. doi:10.1038/s41598-020-64356-y
   PubMed Web of Science ®Google Scholar
• Corbet C, Bastien E, Draoui N, et al. Interruption of lactate uptake by inhibiting mitochondrial pyruvate transport unravels direct antitumor and radiosensitizing effects. Nat Commun. 2018;9(1):1208. doi:10.1038/s41467-018-03525-0
   PubMed Web of Science ®Google Scholar
• Yang S, Wang J, Cheng R, Pang B, Sun P. LINC00035 Transcriptional Regulation of SLC16A3 via CEBPB Affects Glycolysis and Cell Apoptosis in Ovarian Cancer. Evid Based Complement Alternat Med. 2021;2021:5802082. doi:10.1155/2021/5802082
   PubMed Web of Science ®Google Scholar